C4 Therapeutics, Inc.
CCCC
$2.68
-$0.14-4.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.57% | -0.25% | -12.17% | -4.20% | -3.20% |
| Total Receivables | 203.15% | -73.12% | 158.80% | -70.00% | 786.12% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.25% | -14.89% | -3.49% | 34.71% | -32.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -7.95% | -3.36% | -9.79% | -5.66% | -1.02% |
|
|
|||||
| Total Current Assets | -7.95% | -3.36% | -9.79% | -5.66% | -1.02% |
| Net Property, Plant & Equipment | -21.19% | -2.62% | -3.18% | -3.05% | -2.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.91% | -39.71% | -1.51% | -29.91% | 43.56% |
| Total Assets | -10.47% | -7.20% | -8.60% | -7.04% | -1.32% |
|
|
|||||
| Total Accounts Payable | -39.85% | 224.45% | -48.57% | -11.70% | 64.73% |
| Total Accrued Expenses | -20.52% | 11.37% | -38.53% | 28.88% | 52.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.47% | 2.48% | 2.51% | 2.52% | 2.53% |
| Total Finance Division Other Current Liabilities | -21.99% | 3.12% | 14.00% | -8.86% | -41.92% |
| Total Other Current Liabilities | -21.99% | 3.12% | 14.00% | -8.86% | -41.92% |
| Total Current Liabilities | -19.14% | 8.91% | -9.64% | 4.35% | -20.13% |
|
|
|||||
| Total Current Liabilities | -19.14% | 8.91% | -9.64% | 4.35% | -20.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.83% | -2.72% | -2.56% | -2.41% | -2.32% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -5.97% | -15.79% | -11.74% | -0.67% | 69.41% |
| Total Liabilities | -9.30% | -1.54% | -6.91% | 0.16% | -0.47% |
|
|
|||||
| Common Stock & APIC | 1.44% | 0.59% | 0.65% | 0.99% | 2.36% |
| Retained Earnings | -4.69% | -3.94% | -4.15% | -5.77% | -4.29% |
| Treasury Stock & Other | 390.00% | -169.77% | -18.87% | -88.35% | 203.41% |
| Total Common Equity | -11.29% | -10.80% | -9.65% | -10.99% | -1.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.29% | -10.80% | -9.65% | -10.99% | -1.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.29% | -10.80% | -9.65% | -10.99% | -1.78% |
|
|
|||||